Cargando…

Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival

BACKGROUND: Chronic inflammation is a hallmark of cancer, and it can be stimulated by many factors. Substance P (SP), through binding to neurokinin 1 receptor (NK1R), and pyruvate kinase M2 (PKM2) play critical roles in cancer development and progression via modulating the tumor microenvironment. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Keilani, Maha S., Bdeir, Roba, Elstaty, Rana I., Alqudah, Mohammad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936699/ https://www.ncbi.nlm.nih.gov/pubmed/36797689 http://dx.doi.org/10.1186/s12885-023-10633-8

Ejemplares similares

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index
por: Al-Keilani, Maha S., et al.
Publicado: (2022)

Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index
por: Al-Keilani, Maha S., et al.
Publicado: (2021)

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor
por: Nguyen, Lan Phuong, et al.
Publicado: (2023)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma
por: Mehboob, Riffat, et al.
Publicado: (2021)

Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells
por: Koh, Yung-Hua, et al.
Publicado: (2012)

Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer
por: Coveñas, Rafael, et al.
Publicado: (2022)

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma
por: Laurinavicius, Arvydas, et al.
Publicado: (2015)

Structural insights into the activation of neurokinin 2 receptor by neurokinin A
por: Sun, Wenjing, et al.
Publicado: (2022)

Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium
Publicado: (1993)

Selective G protein signaling driven by Substance P-Neurokinin Receptor dynamics
por: Harris, Julian A., et al.
Publicado: (2021)

The substance P and neurokinin-1 receptor system in human thyroid cancer: An immunohistochemical study
por: Isorna, Inmaculada, et al.
Publicado: (2020)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
por: Conklin, Melissa, et al.
Publicado: (2023)

Role of protein kinase C in caerulein induced expression of substance P and neurokinin-1-receptors in murine pancreatic acinar cells
por: Koh, Yung-Hua, et al.
Publicado: (2011)

Neurokinin-1 Receptor Inhibition and Cough
por: Turner, Richard D., et al.
Publicado: (2021)

Neurokinin 1 Receptor Antagonists for Pruritus
por: Alam, Majid, et al.
Publicado: (2021)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
por: Park, Seongyeol, et al.
Publicado: (2016)

Substance P and Neurokinin 1 receptor - expression is affected in the ileum of mice with mutation in the W locus
por: Faussone-Pellegrini, Maria-Simonetta, et al.
Publicado: (2006)

Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P
por: Burmeister, Amanda R., et al.
Publicado: (2017)

Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?
por: Mehboob, Riffat, et al.
Publicado: (2021)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
por: Azizan, Nornazirah, et al.
Publicado: (2018)

High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis
por: Chen, Xiao-Yi, et al.
Publicado: (2016)

Vitamin D Receptor, Retinoid X Receptor, Ki-67, Survivin, and Ezrin Expression in Canine Osteosarcoma
por: Davies, John, et al.
Publicado: (2012)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Neurokinin-1 Receptor Activation in Globus Pallidus
por: Chen, Lei, et al.
Publicado: (2009)

The pharmacology of neurokinin receptors in addiction: prospects for therapy
por: Sandweiss, Alexander J, et al.
Publicado: (2015)

Neurokinin-1 Receptor Antagonists against Hepatoblastoma
por: Muñoz, Miguel, et al.
Publicado: (2019)

Neurokinin receptors and their implications in various autoimmune diseases
por: Mishra, Amrita, et al.
Publicado: (2021)

Functional Neurokinin and NMDA Receptor Activity in an Animal Naturally Lacking Substance P: The Naked Mole-Rat
por: Brand, Antje, et al.
Publicado: (2010)

Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala
por: Khom, S., et al.
Publicado: (2020)

Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature
por: Esteban, Francisco, et al.
Publicado: (2021)

Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies
por: Isorna, Inmaculada, et al.
Publicado: (2023)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian women
por: Singhai, Rajeev, et al.
Publicado: (2011)

Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
por: Ge, Wen-kai, et al.
Publicado: (2015)

Optimization of Novel Antagonists to the Neurokinin-3 Receptor for the Treatment of Sex-Hormone Disorders (Part II)
por: Hoveyda, Hamid R., et al.
Publicado: (2015)

Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese breast cancer patients: A retrospective study of 525 patients
por: Wu, Yu-tuan, et al.
Publicado: (2018)

Immunohistochemical Profiling of HER-2/neu, Steroid Hormone Receptors and KI-67 Biomarkers in A Cohort of Nigerian Women with Breast Cancer
por: Ayandipo, Omobolaji O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4j9m82j588jq3593v8s3mapruh